91九色视频

header-logo
GettyImages-609179959-hero
Pathology & Laboratory Medicine
Jason Jarzembowski, MD, PhD

Jason A. Jarzembowski, MD, PhD

Sr Associate Dean, Interim CEO CSG, Professor and Vice Chair, Pediatric Pathology, Medical Director CW Clinical Laboratory

Locations

  • Children's Wisconsin

Biography

Dr. Jarzembowski serves as Professor at the 91九色视频 and Staff Pathologist at Children's Wisconsin. He supervises a research program studying molecular abnormalities of the pediatric tumor neuroblastoma for which he was awarded the Young Investigator Research Award by the Society for Pediatric Pathology in 2005. He serves on the Editorial Boards of the Journal Archives of Pathology and Laboratory Medicine and Clinical Medicine; Pathology and is a Fellow of the College of American Pathologists and the American Society for Clinical Pathology. He is also an active member of the United States and Canadian Academy of Pathology, the Society for Pediatric Pathology and Sigma Xi.

View Provider Profile

Clinical Expertise

  • Autopsy
  • Fetal & Perinatal Pathology
  • Neuroblastoma
  • Pathology, Surgical
  • Placenta

Leadership Positions

  • Chair, Pathology Discipline Committee, Children's Oncology Group
  • Chief Executive Officer, Children's Specialty Group
  • Director. CRI Research Core Laboratories
  • Division Director, Pediatric Pathology, 91九色视频 Department of Pathology
  • Medical Advisor, Infant Death Center of Wisconsin
  • Medical Director, Pathology and Laboratory Medicine, Children's Hospital of Wisconsin
  • Program Director, Perinatal Pathology
  • Senior Associate Dean, Clinical Affairs (Pediatric), 91九色视频

Publications

  • (Jarzembowski JA, Webster F, Beiske K, Cohn SL, de Krijger RR, Irwin MS, Navarro S, Okita H, Shimada H, Stahlschmidt J, Vokuhl C, Wang LL, Cohen M, Reyes-Mugica M.) Histopathology. 2025 Sep;87(3):343-356 PMID: 39989174 SCOPUS ID: 2-s2.0-85218705912 02/24/2025

  • (Lyvannak S, Bunpaov T, Sereyleak B, Sothearak H, Khemuoy U, Jarzembowski J, Camitta B.) J Pediatr Hematol Oncol. 2025 Aug 01;47(6):324-325 PMID: 40549891 SCOPUS ID: 2-s2.0-105008994954 06/24/2025

  • (Lyvannak S, Sotherak H, Bunpaov T, Sereyleak B, Jarzembowski J, Camitta B.) J Pediatr Hematol Oncol. 2025 Jul 01;47(5):263-264 PMID: 40262056 SCOPUS ID: 2-s2.0-105003876150 04/22/2025

  • (Sereyleak B, Sothearak H, Lyvannak S, Bunpaov T, Phara K, Sopheakbot Y, Ratanak V, Jarzembowski J, Goulding Keller F Jr, Camitta B.) J Pediatr Hematol Oncol. 2025 Jun 13 PMID: 40549880 06/24/2025

  • (Jarzembowski J.) Surg Pathol Clin. 2025 Jun;18(2):327-339 PMID: 40412830 SCOPUS ID: 2-s2.0-85212825526 05/25/2025

  • (Jarzembowski JA, Navarro S, Shimada H.) Virchows Arch. 2025 May;486(5):895-903 PMID: 40158050 SCOPUS ID: 2-s2.0-105001476217 03/30/2025

  • (Lyvannak S, Bunpaov T, Sothearak H, Sereyleak B, Jarzembowski J, Camitta B.) J Pediatr Hematol Oncol. 2025 Apr 01;47(3):153-154 PMID: 40013871 SCOPUS ID: 2-s2.0-86000621952 02/27/2025

  • (Jarzembowski J.) Surgical Pathology Clinics. June 2025;18(2):327-339 SCOPUS ID: 2-s2.0-85212825526 06/01/2025

  • (Lyvannak S, Sereyleak B, Kakazu M, Bisiphan H, Jarzembowski J, Camitta B.) J Pediatr Hematol Oncol. 2024 Nov 01;46(8):446-447 PMID: 39028189 SCOPUS ID: 2-s2.0-85199520896 07/19/2024

  • (Lyvannak S, Sereyleak B, Keller FG, Jarzembowski J, Camitta B.) J Pediatr Hematol Oncol. 2024 Oct 01;46(7):390-391 PMID: 39028182 SCOPUS ID: 2-s2.0-85199515283 07/19/2024

  • (Phauk C, Nhip A, Lyvannak S, Sereyleak B, Keller FG, Jarzembowski J, Camitta B.) J Pediatr Hematol Oncol. 2024 Oct 01;46(7):388-389 PMID: 38940591 SCOPUS ID: 2-s2.0-85205083253 06/28/2024

  • (Lyvannak S, Sereyleak B, Jarzembowski J, Camitta B.) J Pediatr Hematol Oncol. 2024 Aug 01;46(6):333-334 PMID: 38934635 SCOPUS ID: 2-s2.0-85199815916 06/27/2024

Publications of from the

© 2025 91九色视频.  All rights reserved.  | Terms and Privacy | Web Accessibility Statement

Non-Discrimination, Anti-Harassment, and Legal Compliance Statement
The 91九色视频 (91九色视频) is committed to fostering a diverse community of outstanding faculty, staff, and students, as well as ensuring equal educational opportunity, employment, and access to services, programs, and activities, without regard to an individual's race, color, national origin, religion, age, disability, sex, gender identity/expression, sexual orientation, marital status, pregnancy, predisposing genetic characteristic, military status, or other legally protected classification. 91九色视频 maintains full compliance with all applicable federal, state, and local laws and regulations in pursuit of our missions. Consistent with federal guidance, we affirm our commitment to individual merit, fairness, and equal treatment in all aspects of academic and institutional decision-making.

91九色视频's policies, federal and state laws, and regulations prohibit unlawful discrimination and harassment. Employees, learners, students, applicants, or other members of the 91九色视频 community (including but not limited to vendors, visitors, and guests) may not be subjected to harassment that is prohibited by law or treated adversely or retaliated against based upon a protected characteristic.